Showing results (2301-2310 of 2,545) with videos related to
Sort By:
Pageof 255
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2017
CRISPR-Cas9-mediated saturated mutagenesis screen predicts clinical drug resistance with improved accuracyLeyuan Ma, Jeffrey I Boucher, Janet Paulsen, et al.Skeletal Muscle|June 2, 2018
TRAPPC11 and GOSR2 mutations associate with hypoglycosylation of α-dystroglycan and muscular dystrophyAustin A Larson, Peter R Baker, Miroslav P Milev, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2023
Clinical outcomes and toxicities of 100 patients treated with proton therapy for chordoma on the proton collaborative group prospective registryArpit M Chhabra, Stephanie R Rice, Adam Holtzman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2012
Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-Hodgkin lymphoma: SWOG S0016Oliver W Press, Joseph M Unger, Lisa M Rimsza, et al.Blood|April 20, 2002
High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphomaAjay K Gopal, Joseph G Rajendran, Stephen H Petersdorf, et al.Journal of Neuro-Oncology|December 22, 2016
Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysisKirtesh R Patel, Stuart H Burri, Danielle Boselli, et al.Journal of Neurosurgery|April 21, 2018
Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastasesJaymin Jhaveri, Mudit Chowdhary, Xinyan Zhang, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantationRyan D Cassaday, Barry E Storer, Mohamed L Sorror, et al.Cancer|August 19, 2018
Targeted sequencing and intracranial outcomes of patients with lung adenocarcinoma brain metastases treated with radiotherapyRobert H Press, Chao Zhang, Richard J Cassidy, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2015
PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab ResistanceHoward M Stern, Humphrey Gardner, Tomasz Burzykowski, et al.Pageof 255